Neural Regeneration Research ›› 2014, Vol. 9 ›› Issue (17): 1581-1584.doi: 10.4103/1673-5374.141782

Previous Articles     Next Articles

Induction of ischemic tolerance as a promising treatment against diabetic retinopathy

Ruth E. Rosenstein 1, Diego C. Fernandez 1, 2   

  1. 1 Laboratory of Retinal Neurochemistry and Experimental Ophthalmology, Department of Human Biochemistry, School of Medicine/CEFyBO, University of Buenos Aires/CONICET, Buenos Aires, Argentina
    2 Present address: Johns Hopkins University, Department of Biology, Baltimore, MD, USA
  • Received:2014-08-12 Online:2014-09-16 Published:2014-09-16
  • Contact: Ruth E. Rosenstein, Departamento de Bioquímica Humana, Facultad de Medicina, /CEFyBO, UBA/CONICET. Paraguay 2155, 5°P, (1121), Buenos Aires, Argentina. ruthr@fmed.uba.ar.

Abstract:

Diabetic retinopathy is a leading cause of acquired blindness, and it is the most common ischemic disorder of the retina. Available treatments are not very effective. Efforts to inhibit diabetic retinopathy have focused either on highly specific therapeutic approaches for pharmacologic targets or using genetic approaches to change expression of certain enzymes. However, it might be wise to choose innovative treatment modalities that act by multiple potential mechanisms. The resistance to ischemic injury, or ischemic tolerance, can be transiently induced by prior exposure to a non-injurious preconditioning stimulus. A complete functional and histologic protection against retinal ischemic damage can be achieved by previous preconditioning with non-damaging ischemia. In this review, we will discuss evidence that supports that ischemic conditioning could help avert the dreaded consequences that results from retinal diabetic damage.

Key words: diabetic retinopathy, ischemic tolerance, etina, ischemic injury, ischemic conditioning